A compound represented by the formula (I), an optically active isomer thereof, or a pharmaceutical acceptable salt thereof: wherein X represents CH or N; represents a C.sub.1-C.sub.12 alkyl; R.sup.2 represents a hydrogen atom, or the like; R' represents a C.sub.1-C.sub.6 alkyl or the like; q represents 0 or an integer of 1 to 7; Y represents a C.sub.1-C.sub.6 alkyl or the like; p represents 0 or an integer of 1 to 5; R represents a 2,3-dihydroindolyl or the like, which is used for preventive and/or therapeutic treatment of a disease caused by tau protein kinase 1 hyperactivity such as a neurodegenerative diseases (e.g. Alzheimer disease). ##STR00001##

 
Web www.patentalert.com

< Method of selective breeding based on ob genotype

> Novel Pyrimidine-2,4-Diamine Derivatives and their Use as Modulators of Small-Conductance Calcium-Activated Potassium Channels

> AZA SPIRO ALKANE DERIVATIVES AS INHIBITORS OF METALLOPROTEASES

~ 00517